Mangani D, Subramanian A, Huang L, et al. Transcription factor TCF1 binds to RORγt and orchestrates a regulatory network that determines homeostatic Th17 cell state. Immunity. 2024. doi:10.1016/j.immuni.2024.09.017
Jeong S, Tsai MJ, Shen C, Hsu YH. Falls, fracture and frailty risk in multiple sclerosis: a Mendelian Randomization study to identify shared genetics. Journal of bone and mineral metabolism. 2024. doi:10.1007/s00774-024-01504-8
Tanasescu R, Frakich N, Chou IJ, et al. Natalizumab Treatment of Relapsing Remitting Multiple Sclerosis Has No Long-Term Effects on the Proportion of Circulating Regulatory T Cells. Neurology and therapy. 2023. doi:10.1007/s40120-023-00539-9
Rojo D, Dal Cengio L, Badner A, et al. BMAL1 loss in oligodendroglia contributes to abnormal myelination and sleep. Neuron. 2023. doi:10.1016/j.neuron.2023.08.002
Dhand A, White CC, Johnson C, Xia Z, De Jager PL. A scalable online tool for quantitative social network assessment reveals potentially modifiable social environmental risks. Nat Commun. 2018;9(1):3930. doi:10.1038/s41467-018-06408-6
Wheeler MA, Quintana FJ. Regulation of Astrocyte Functions in Multiple Sclerosis. Cold Spring Harb Perspect Med. 2019;9(1). doi:10.1101/cshperspect.a029009
Patsopoulos NA. Genetics of Multiple Sclerosis: An Overview and New Directions. Cold Spring Harb Perspect Med. 2018;8(7). doi:10.1101/cshperspect.a028951
Hu D, Notarbartolo S, Croonenborghs T, et al. Transcriptional signature of human pro-inflammatory T17 cells identifies reduced IL10 gene expression in multiple sclerosis. Nat Commun. 2017;8(1):1600. doi:10.1038/s41467-017-01571-8
Quintana FJ. Astrocytes play a crucial role in the formation and evolution of MS lesions - Commentary. Mult Scler. 2019;25(1):19-20. doi:10.1177/1352458518796693
Manousaki D, Dudding T, Haworth S, et al. Low-Frequency Synonymous Coding Variation in CYP2R1 Has Large Effects on Vitamin D Levels and Risk of Multiple Sclerosis. Am J Hum Genet. 2017;101(2):227-238. doi:10.1016/j.ajhg.2017.06.014